Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Sign in!
Subscribe
Clinical Topics
View All
Addiction
ADHD
Anxiety
Bipolar Disorder
Depression
Emerging Approaches in Schizophrenia
Movement Disorders
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia/Schizoaffective Disorders
Sleep
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
View All
Purva Barot, MBA, BPharm
a:1:{i:0;s:45:"IQVIA Solutions Canada, Inc, Kirkland, Canada";}
JCP
Original Research
Medication Use and Lines of Treatment in Patients With Insomnia Disorder
September 11, 2024
In this Canadian study, the annual cost of medications for insomnia was $54.8 million, and $30.3 million (55.2%) met inappropriate medication use criteria.
Shabbir Amanullah
,
Laveena Kamboj
,
Barbara Ramos
, et al
